Clinical Trial Update: Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating the PET tracer [18F] Fluoroethyl-L-tyrosine combined with MRI to identify small functional pituitary adenomas. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pituitary Adenoma

Drugs mentioned

• [18F] Fluoroethyl-L-tyrosine (Fluoroethyl-L-tyrosine)

Snippet

Sponsor: Mayo Clinic | Conditions: Pituitary Adenoma | Phase 1 | Status: RECRUITING